Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor

Biochemical and Biophysical Research Communications

Volumn 278, Issue 1, 2000, Pages 38-43

  Dey, Bhakta R ^a   Furlanetto, Richard W ^b   Nissley, Peter ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Insulin receptor; Phospho SOCS 3; Yeast two hybrid

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; CYTOKINE SIGNALING PROTEIN 3; INSULIN RECEPTOR; PROTEIN; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; EMBRYO; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; TISSUE DISTRIBUTION; YEAST;

JANUS; MAMMALIA;

EID: 0034638630     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3762     Document Type: Article

References (23)

1. Negative regulation of the JAK/STAT pathway
2. The CIS family: Negative regulators of JAK-STAT signaling
3. Cytokine signaling: Cytokine-inducible signaling inhibitors
4. Evidence for the direct interaction of the insulin-like growth factor-I receptor with IRS-1, Shc and Grb10
5. Cloning of human p55γ, a regulatory subunit of phosphatidylinositol 3-kinase, by a yeast two-hybrid library screen with the insulin-like growth factor-I receptor
6. 14-3-3 Proteins interact with the insulin-like growth factor receptor but not the insulin receptor
7. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor
8. A family of cytokine-inducible inhibitors of signalling
9. Cloning and functional analysis of new members of STAT-induced STAT inhibitors (SSI) family
10. Cloning and characterization of novel CIS family genes
11. Differential ability of SOCS proteins to regulate IL-6 and CSF-1 induced macrophage differentiation
12. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
13. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation
14. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
15. Growth hormone regulation of SOCS-2, SOCS-3 and CIS messenger ribonucleic acid expression in the rat
16. Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion
17. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling
18. Identification of SOCS-3 as a potential mediator of central leptin resistance
19. Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor
20. SOCS3 is essential in the regulation of fetal liver erythropoiesis
21. SOCS-3 is an insulin-induced negative regulator of insulin signaling
22. Cytokine-inducible SH2 (CIS3/SOCS3) inhibits Janus tyrosine by binding through the N-terminal kinase inhibitory region as well as SH2 domain